# Comparison of Three Commercial Batches of the Japanese Encephalitis Vaccine IC51

> **NCT00595465** · PHASE3 · COMPLETED · sponsor: **Valneva Austria GmbH** · enrollment: 389 (actual)

## Conditions studied

- Japanese Encephalitis

## Interventions

- **BIOLOGICAL:** Japanese Encephalitis purified inactivated vaccine

## Key facts

- **NCT ID:** NCT00595465
- **Lead sponsor:** Valneva Austria GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12
- **Primary completion:** 2008-02
- **Final completion:** 2008-06
- **Target enrollment:** 389 (ACTUAL)
- **Last updated:** 2014-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00595465

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00595465, "Comparison of Three Commercial Batches of the Japanese Encephalitis Vaccine IC51". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT00595465. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*